MRI device
DeviceStandered breast coils with small field of veiw and thin sections will be used for the examinatio.
MRI breast including Axial T1WI, T2WI Stir contrast DWI and Stir sagittal T1WI with contrast traction and subtraction
NCT Number: NCT06494865
Breast MRI has become an important tool for breast cancer detection and characterization.Contrast enhanced MRI(CE-MRI) is currently the most sensitive detection technique for diagnosis of breast cancer.
Trial opening soon.
Get Notified18 year–70 year
Female
Observational
Most of the lesions that occur in the breast are benign lesions. It is important to recognize benign lesions and distinguish them from breast cancer.
Nowadays sonomammography still represents the primary imaging modality utilized for breast cancer screening and diagnosis.
Breast MRI has become an important tool for breast cancer detection and characterization.Contrast enhanced MRI(CE-MRI) is currently the most sensitive detection technique for diagnosis of breast cancer.Diffusion weighted imaging provides micro-structural informations regadrding the diffusion of the water molecules in the tissue cellularity and tissue structure by using the quantitive analysis with the apparent diffusion coefficient (ADC) values.
Using Diffusion weighted imaging (DWI) combined to MRI is helpful to distinguish malignant versus benign breast lesions and it also may reduce the number of unnecessarily breast biopsies.
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Standered breast coils with small field of veiw and thin sections will be used for the examinatio.
MRI breast including Axial T1WI, T2WI Stir contrast DWI and Stir sagittal T1WI with contrast traction and subtraction
Time frame: 6 months
evaluation of the lesion with MRI DWI and histopathology for detect rate of false posive results
Contact information is provided by the study sponsor or research team.
Medhat I Mohammed, professor
CONTACT
Mennatullah A Ibrahim, resident
CONTACT
Sohag University
Other
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07619534
Breast Cancer, Breast Carcinoma
Bethesda, Maryland, United States
View Trial DetailsNCT07735897
Breast Cancer, Breast Diseases
Seoul, Sondpagu, South Korea
View Trial DetailsNCT07739563
Behavior, Breast Cancer
Pittsburgh, Pennsylvania, United States
View Trial DetailsNCT07737132
Breast Cancer, Breast Diseases
View Trial Details